Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: Mar 20, 2026

Murine Bilateral Renal Lymphadenectomy
06:20

Murine Bilateral Renal Lymphadenectomy

Published on: December 30, 2025

132

Lymph node dissection for renal cell carcinoma: what are we missing?

Marco Moschini1, Paolo Dell'Oglio, Alessandro Larcher

  • 1aUnit of Urology, University Vita-Salute bDivision of Experimental Oncology, Urological Research Institute, IRCCS San Raffaele Scientific Institute, Milan, Italy cDepartment of Urology, Comprehensive Cancer Center, Medical University of Vienna, Vienna General Hospital, Vienna, Austria.

Current Opinion in Urology
|June 5, 2016
PubMed
Summary

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Ten-year update on the European Association of Urology Robotic Section (ERUS) fellowship training for robot-assisted radical prostatectomy.

BJUI compass·2026
Same author

What should the urologist know on the management of kidney cancer in patients with Von Hippel-Lindau syndrome? Recommendations of the European Association of Urology (EAU) Young Academic Urologists (YAU) Renal Cancer Working Group.

World journal of urology·2026
Same author

A preoperative Artificial Intelligence model to estimate cancer-specific mortality in nonmetastatic kidney cancer patients.

Nature communications·2026
Same author

First-in-human <i>ex-vivo</i> validation of carbonic anhydrase IX-PET for high-risk renal cancer (CAT-VHL - PNRR-POC-2023-12377493).

Theranostics·2026
Same author

Interpreting Matched Analyses of Partial Versus Radical Nephrectomy for cT2 Tumors: Methodological Caveats and Clinical Implications.

The Journal of urology·2026
Same author

Active surveillance for renal masses up to 2 cm: long-term oncological outcomes from a prospective multi-institutional study.

World journal of urology·2026

The role of lymph node dissection (LND) in renal cell carcinoma (RCC) remains uncertain. Current evidence suggests LND is primarily for staging in advanced RCC, but more research is needed to clarify its impact.

Area of Science:

  • Urology
  • Oncology
  • Surgical Oncology

Background:

  • The clinical significance of lymph node dissection (LND) in renal cell carcinoma (RCC) is not well-established.
  • Current diagnostic tools have limited ability to predict which RCC patients might benefit from LND.

Purpose of the Study:

  • To review existing literature on the role and impact of LND in surgically treated RCC patients.
  • To identify controversies, uncertainties, and future research directions regarding LND in RCC.

Main Methods:

  • Comprehensive literature review of studies investigating lymph node dissection in renal cell carcinoma.
  • Assessment of current evidence regarding the utility of imaging and risk scores for LND candidacy.

Main Results:

More Related Videos

Robot-assisted Total Mesorectal Excision and Lateral Pelvic Lymph Node Dissection for Locally Advanced Middle-low Rectal Cancer
12:45

Robot-assisted Total Mesorectal Excision and Lateral Pelvic Lymph Node Dissection for Locally Advanced Middle-low Rectal Cancer

Published on: February 12, 2022

6.9K
Microdissection of Primary Renal Tissue Segments and Incorporation with Novel Scaffold-free Construct Technology
09:00

Microdissection of Primary Renal Tissue Segments and Incorporation with Novel Scaffold-free Construct Technology

Published on: March 27, 2018

8.0K

Related Experiment Videos

Last Updated: Mar 20, 2026

Murine Bilateral Renal Lymphadenectomy
06:20

Murine Bilateral Renal Lymphadenectomy

Published on: December 30, 2025

132
Robot-assisted Total Mesorectal Excision and Lateral Pelvic Lymph Node Dissection for Locally Advanced Middle-low Rectal Cancer
12:45

Robot-assisted Total Mesorectal Excision and Lateral Pelvic Lymph Node Dissection for Locally Advanced Middle-low Rectal Cancer

Published on: February 12, 2022

6.9K
Microdissection of Primary Renal Tissue Segments and Incorporation with Novel Scaffold-free Construct Technology
09:00

Microdissection of Primary Renal Tissue Segments and Incorporation with Novel Scaffold-free Construct Technology

Published on: March 27, 2018

8.0K
  • LND in RCC is mainly indicated for staging in cases with larger tumors, locally advanced disease, or adverse features like lymphadenopathy.
  • Salvage LND is being considered, but lacks definitive recommendations.
  • Limited and imperfect data hinder a clear assessment of LND's role and effect in RCC.

Conclusions:

  • Further basic, translational, and imaging research is crucial to elucidate the role of LND in RCC management.
  • The current understanding of LND's impact on RCC prognosis is limited by data quality.